Enzaplatovir
Enzaplatovir (BTA-585) is an orally available fusion inhibitor with antiviral activity for the study of respiratory syncytial virus infections and coronavirus disease (COVID-19) infections.
Product Specifications
CAS Number
1323077-89-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
377.4
Molecular Formula
C20H19N5O3
Notes
Research use only, not for human use.
Receptor
RSV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
sc-345949A 1 g
3-[4- (2-Chloro-phenylsulfamoyl) -phenyl]-acrylic acid
Sign In for Pricing
View Details NBP2-89413AF405 0.1 mL
Rabbit Monoclonal Glucosamine (N-acetyl)-6-Sulfatase/GNS Antibody (007) [Alexa Fluor 405]
Sign In for Pricing
View Details